Digestive and biliary disorders:
Indications for: VIOKACE
Treatment of exocrine pancreatic insufficiency in adults due to chronic pancreatitis or pancreatectomy, in combination with a proton pump inhibitor.
Adult Dosage:
Start at the lowest recommended dose and increase gradually. Individualize based on clinical symptoms, the degree of steatorrhea present, and the fat content of the diet. Swallow whole; do not crush or chew tabs. Take with meals and sufficient fluid. Do not let any drug remain in mouth. Initially 500 lipase units/kg per meal. Max: 2500 lipase units/kg per meal (or ≤10000 lipase units/kg/day), or <4000 lipase units/g fat ingested per day. See full labeling.
Children Dosage:
Not established.
VIOKACE Warnings/Precautions:
Not interchangeable with other pancrelipase products. Fibrosing colonopathy (with high doses); risk of stricture formation (monitor). Pork allergy. Potential viral transmission. Gout. Renal impairment. Hyperuricemia. Contents irritating to oral mucosa. Lactose intolerance. Pregnancy (Cat.C). Nursing mothers.
VIOKACE Classification:
Pancreatic enzymes (porcine).
Adverse Reactions:
Biliary tract stones, anal pruritus; allergic reactions.
How Supplied:
Tabs—100
